DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 78,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Mr. Javier Rodriguez es el Chief Executive Officer de DaVita Inc, se unió a la empresa desde 2000.
¿Qué tal es el rendimiento del precio de la acción DVA?
El precio actual de DVA es de $152.3, ha aumentado un 0.06% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de DaVita Inc?
DaVita Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de DaVita Inc?
La capitalización bursátil actual de DaVita Inc es $10.1B
¿Es DaVita Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 10 analistas han realizado calificaciones de análisis para DaVita Inc, incluyendo 0 fuerte compra, 1 compra, 10 mantener, 5 venta, y 0 fuerte venta